Invitrogen Invests In Q Therapeutics
Carlsbad-based Invitrogen, a provider of services to the pharmaceutical and biotech market, said Friday that it has made a minority invevstment in Q Therapeutics, a biotechnology firm focused on treatments for central nervous system diseases. Financial terms of the investment were not disclosed. Q Therapeutics is based in Salt Lake City, Utah. Invitrogen is a $1.3B life science technologies with over 4,700 employees.
posted on Friday, February 15, 2008
> Invitrogen Releases Equipment
> Invitrogen Appoints Execs
> Invitrogen Ties Into Procurement
> Invitrogen Acquires CellzDirect
> Invitrogen Merges With Applied Biosystems In $6.7B Deal